Global Retinal Biologics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Retinal Biologics Market Overview

• 1.1 Product Overview and Scope of Retinal Biologics
• 1.2 Classification of Retinal Biologics by Types
  • 1.2.1 Global Retinal Biologics Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Retinal Biologics Revenue Market Share by Types in 2018
  • 1.2.3 Macular Degeneration
  • 1.2.4 Diabetic Retinopathy
  • 1.2.5 Diabetic Macular Edema
  • 1.2.6 Uveitis
  • 1.2.7 Others
• 1.3 Global Retinal Biologics Market by Application
  • 1.3.1 Global Retinal Biologics Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Others
• 1.4 Global Retinal Biologics Market by Regions
  • 1.4.1 Global Retinal Biologics Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Retinal Biologics Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Retinal Biologics Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Retinal Biologics Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Retinal Biologics Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Retinal Biologics Status and Prospect (2014-2024)
• 1.5 Global Market Size of Retinal Biologics (2014-2024)

2 Manufacturers Profiles

• 2.1 Spark Therapeutics, Inc
  • 2.1.1 Business Overview
  • 2.1.2 Retinal Biologics Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Spark Therapeutics, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 F. Hoffmann-La Roche Ltd
  • 2.2.1 Business Overview
  • 2.2.2 Retinal Biologics Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Regeneron Pharmaceuticals, Inc
  • 2.3.1 Business Overview
  • 2.3.2 Retinal Biologics Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 AbbVie Inc
  • 2.4.1 Business Overview
  • 2.4.2 Retinal Biologics Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 AbbVie Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Johnson & Johnson Services, Inc
  • 2.5.1 Business Overview
  • 2.5.2 Retinal Biologics Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Johnson & Johnson Services, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Amgen Inc
  • 2.6.1 Business Overview
  • 2.6.2 Retinal Biologics Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Amgen Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2018)

3 Global Retinal Biologics Market Competition, by Players

• 3.1 Global Retinal Biologics Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Retinal Biologics Players Market Share
  • 3.2.2 Top 10 Retinal Biologics Players Market Share
• 3.3 Market Competition Trend

4 Global Retinal Biologics Market Size by Regions

• 4.1 Global Retinal Biologics Revenue and Market Share by Regions
• 4.2 North America Retinal Biologics Revenue and Growth Rate (2014-2019)
• 4.3 Europe Retinal Biologics Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Retinal Biologics Revenue and Growth Rate (2014-2019)
• 4.5 South America Retinal Biologics Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Retinal Biologics Revenue and Growth Rate (2014-2019)

5 North America Retinal Biologics Revenue by Countries

• 5.1 North America Retinal Biologics Revenue by Countries (2014-2019)
• 5.2 USA Retinal Biologics Revenue and Growth Rate (2014-2019)
• 5.3 Canada Retinal Biologics Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Retinal Biologics Revenue and Growth Rate (2014-2019)

6 Europe Retinal Biologics Revenue by Countries

• 6.1 Europe Retinal Biologics Revenue by Countries (2014-2019)
• 6.2 Germany Retinal Biologics Revenue and Growth Rate (2014-2019)
• 6.3 UK Retinal Biologics Revenue and Growth Rate (2014-2019)
• 6.4 France Retinal Biologics Revenue and Growth Rate (2014-2019)
• 6.5 Russia Retinal Biologics Revenue and Growth Rate (2014-2019)
• 6.6 Italy Retinal Biologics Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Retinal Biologics Revenue by Countries

• 7.1 Asia-Pacific Retinal Biologics Revenue by Countries (2014-2019)
• 7.2 China Retinal Biologics Revenue and Growth Rate (2014-2019)
• 7.3 Japan Retinal Biologics Revenue and Growth Rate (2014-2019)
• 7.4 Korea Retinal Biologics Revenue and Growth Rate (2014-2019)
• 7.5 India Retinal Biologics Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Retinal Biologics Revenue and Growth Rate (2014-2019)

8 South America Retinal Biologics Revenue by Countries

• 8.1 South America Retinal Biologics Revenue by Countries (2014-2019)
• 8.2 Brazil Retinal Biologics Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Retinal Biologics Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Retinal Biologics Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Retinal Biologics by Countries

• 9.1 Middle East and Africa Retinal Biologics Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Retinal Biologics Revenue and Growth Rate (2014-2019)
• 9.3 UAE Retinal Biologics Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Retinal Biologics Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Retinal Biologics Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Retinal Biologics Revenue and Growth Rate (2014-2019)

10 Global Retinal Biologics Market Segment by Type

• 10.1 Global Retinal Biologics Revenue and Market Share by Type (2014-2019)
• 10.2 Global Retinal Biologics Market Forecast by Type (2019-2024)
• 10.3 Macular Degeneration Revenue Growth Rate (2014-2024)
• 10.4 Diabetic Retinopathy Revenue Growth Rate (2014-2024)
• 10.5 Diabetic Macular Edema Revenue Growth Rate (2014-2024)
• 10.6 Uveitis Revenue Growth Rate (2014-2024)
• 10.7 Others Revenue Growth Rate (2014-2024)

11 Global Retinal Biologics Market Segment by Application

• 11.1 Global Retinal Biologics Revenue Market Share by Application (2014-2019)
• 11.2 Retinal Biologics Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2014-2019)
• 11.4 Clinics Revenue Growth (2014-2019)
• 11.5 Others Revenue Growth (2014-2019)

12 Global Retinal Biologics Market Size Forecast (2019-2024)

• 12.1 Global Retinal Biologics Market Size Forecast (2019-2024)
• 12.2 Global Retinal Biologics Market Forecast by Regions (2019-2024)
• 12.3 North America Retinal Biologics Revenue Market Forecast (2019-2024)
• 12.4 Europe Retinal Biologics Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Retinal Biologics Revenue Market Forecast (2019-2024)
• 12.6 South America Retinal Biologics Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Retinal Biologics Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology